157 related articles for article (PubMed ID: 9341900)
21. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
Zhang Hong
Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder.
Popov Z; Hoznek A; Colombel M; Bastuji-Garin S; Lefrere-Belda MA; Bellot J; Abboh CC; Mazerolles C; Chopin DK
Cancer; 1997 Oct; 80(8):1472-81. PubMed ID: 9338472
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of p53 overexpression in endometrial cancer.
Ito K; Watanabe K; Nasim S; Sasano H; Sato S; Yajima A; Silverberg SG; Garrett CT
Cancer Res; 1994 Sep; 54(17):4667-70. PubMed ID: 8062261
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical analysis of p53 protein in uterine sarcomas.
Nordal RR; Kristensen GB; Stenwig AE; Tropé CG; Nesland JM
Gynecol Oncol; 1998 Jul; 70(1):45-8. PubMed ID: 9698472
[TBL] [Abstract][Full Text] [Related]
25. Nuclear immunoreaction of p53 protein in soft tissue sarcomas. A possible prognostic factor.
Kawai A; Noguchi M; Beppu Y; Yokoyama R; Mukai K; Hirohashi S; Inoue H; Fukuma H
Cancer; 1994 May; 73(10):2499-505. PubMed ID: 8174045
[TBL] [Abstract][Full Text] [Related]
26. P53 is an independent prognostic factor for survival in thyroid cancer.
Bachmann K; Pawliska D; Kaifi J; Schurr P; Zörb J; Mann O; Kahl HJ; Izbicki JR; Strate T
Anticancer Res; 2007; 27(6B):3993-7. PubMed ID: 18225561
[TBL] [Abstract][Full Text] [Related]
27. p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study.
Stefanou DG; Nonni AV; Agnantis NJ; Athanassiadou SE; Briassoulis E; Pavlidis N
Anticancer Res; 1998; 18(6B):4673-81. PubMed ID: 9891539
[TBL] [Abstract][Full Text] [Related]
28. A microwave method that enhances detection of aberrant p53 expression in formalin-fixed, paraffin-embedded tissues.
Resnick JM; Cherwitz D; Knapp D; Uhlman D; Niehans GA
Arch Pathol Lab Med; 1995 Apr; 119(4):360-6. PubMed ID: 7726729
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients.
Gasparini G; Toi M; Verderio P; Ranieri G; Dante S; Bonoldi E; Boracchi P; Fanelli M; Tominaga T
Int J Oncol; 1998 May; 12(5):1117-25. PubMed ID: 9538138
[TBL] [Abstract][Full Text] [Related]
30. Expression of p53 and 17p allelic loss in colorectal carcinoma.
Cunningham J; Lust JA; Schaid DJ; Bren GD; Carpenter HA; Rizza E; Kovach JS; Thibodeau SN
Cancer Res; 1992 Apr; 52(7):1974-80. PubMed ID: 1551126
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis in rectal cancer: prognostic significance in comparison with clinical histopathologic, and immunohistochemical variables.
Schwandner O; Schiedeck TH; Bruch HP; Duchrow M; Windhoevel U; Broll R
Dis Colon Rectum; 2000 Sep; 43(9):1227-36. PubMed ID: 11005488
[TBL] [Abstract][Full Text] [Related]
32. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.
Sarkis AS; Dalbagni G; Cordon-Cardo C; Zhang ZF; Sheinfeld J; Fair WR; Herr HW; Reuter VE
J Natl Cancer Inst; 1993 Jan; 85(1):53-9. PubMed ID: 7677935
[TBL] [Abstract][Full Text] [Related]
33. Accumulation of nuclear p53 protein and prognosis of astrocytomas in childhood and adolescence.
Drach LM; Kammermeier M; Neirich U; Jacobi G; Kornhuber B; Lorenz R; Schlote W
Clin Neuropathol; 1996; 15(2):67-73. PubMed ID: 8925599
[TBL] [Abstract][Full Text] [Related]
34. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas.
Taubert H; Würl P; Meye A; Berger D; Thamm B; Neumann K; Hinze R; Schmidt H; Rath FW
Cancer; 1995 Oct; 76(7):1187-96. PubMed ID: 8630896
[TBL] [Abstract][Full Text] [Related]
35. Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma.
Hasegawa T; Yokoyama R; Lee YH; Shimoda T; Beppu Y; Hirohashi S
Oncology; 2000; 58(1):66-74. PubMed ID: 10644943
[TBL] [Abstract][Full Text] [Related]
36. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.
Folpe AL; Lyles RH; Sprouse JT; Conrad EU; Eary JF
Clin Cancer Res; 2000 Apr; 6(4):1279-87. PubMed ID: 10778952
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of p53 protein in basal cell carcinomas of human skin.
Shea CR; McNutt NS; Volkenandt M; Lugo J; Prioleau PG; Albino AP
Am J Pathol; 1992 Jul; 141(1):25-9. PubMed ID: 1632467
[TBL] [Abstract][Full Text] [Related]
38. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx.
Maestro R; Dolcetti R; Gasparotto D; Doglioni C; Pelucchi S; Barzan L; Grandi E; Boiocchi M
Oncogene; 1992 Jun; 7(6):1159-66. PubMed ID: 1594246
[TBL] [Abstract][Full Text] [Related]
39. P53 overexpression in head and neck carcinoma and radiotherapy results.
Awwad S; Jaros E; Somes J; Lunec J
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):323-32. PubMed ID: 8567333
[TBL] [Abstract][Full Text] [Related]
40. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors.
Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK
J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
